Table 3 Comorbidities of participants with Ménière’s disease.

From: Population-based study for the comorbidities and associated factors in Ménière’s disease

 

Prevalence rate per 1,000 (n)

Univariable analysis

MD

Controls without MD

Adjusted OR (95% CI)

P Value

Autoimmune diseases

 Rheumatic

  Rheumatoid arthritis

2.48 (5)

4.22 (85)

0.587 (0.207–1.307)

0.248

  Ankylosing spondylitis

1.49 (3)

1.14 (23)

1.305 (0.309–3.752)

0.665

  Totala

0.35 (8)

0.64 (129)

0.541 (0.229–1.075)

0.114

 Non-rheumatic

  Type 1 DM

1.49 (3)

3.87 (78)

0.384 (0.094–1.027)

0.104

  Grave’s disease

3.97 (8)

4.37 (88)

0.909 (0.405–1.761)

0.796

  Hashimoto’s thyroiditis

6.46 (13)

4.77 (96)

1.356 (0.723–2.335)

0.304

  Totalb

1.44 (29)

1.43 (288)

1.007 (0.671–0.971)

0.971

 Allergic disease

  Allergic rhinitis

774.47 (1599)

658.82 (6652)

2.000 (1.790–2.240)

< 0.001**

  Allergic asthma

15.90 (32)

10.88 (103)

1.469 (0.992–2.101)

0.044*

 Metabolic disease

  Cerebrovascular

5.96 (12)

5.27 (106)

1.133 (0.590–1.977)

0.683

  Cardiovascular

14.90 (30)

14.21 (286)

1.050 (0.704–1.507)

0.802

Cancer

6.06 (122)

5.68 (572)

1.034 (0.849–1.248)

0.732

Migraine

229.01 (461)

69.05 (1390)

4.005 (3.559–4.500)

< 0.001**

  1. Significant values are in [bold].
  2. aSystemic lupus erythematous, Dermatomyositis/polymyositis, systemic sclerosis, Sjogren’s syndrome, ankylosing spondylitis, rheumatoid arthritis.
  3. b Type 1 diabetes mellitus, grave’s disease, hashimoto’s thyroiditis, crohn’s disease, ulcerative colitis, autoimmune hepatitis.
  4. MD Ménière’s disease, DM Diabetes mellitus.
Back to article page